SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Elan Corporation, plc (ELN)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
10345 171 0 ELN
Emcee:  Harold Engstrom Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10270msnbc.msn.com Interesting story......could it hold a clue to this mystery?Arthur Radley-6/2/2010
10269Don't believe this theory is particularly new. This has been kicked around D.Lu-5/12/2010
10268reuters.com Not good news.......for Elan! If this is true.Arthur Radley-5/12/2010
10267It happened last year-- This adds a little color to the deal, but they did have Arthur Radley-5/10/2010
10266I didn't notice a $900 million infusion of cash into Elan from J & J.steve kammerer-5/10/2010
10265finance.yahoo.comArthur Radley-5/10/2010
10264Anyone considering buying at this level......should they split the company, one Arthur Radley-5/5/2010
10263fool.com Agree....two parts will be better than one, but sure don't want thArthur Radley-4/20/2010
10262Large Body of Data on TYSABRI® to Be Presented at Annual Meeting of the Amesim124/13/2010
10261Wells Fargo Initiates Coverage on Elan Corporation (ELN) with a Market Perform 7Arthur Radley14/12/2010
10260knol.google.com A very interesting blog on the Elan drug.....'appears' Arthur Radley-4/5/2010
10259Hi D Lu, I do not think it will be hard to enroll. My wife was a Copaxone failIRWIN JAMES FRANKEL43/26/2010
10258A large study. Given the risks of TYSABRI, I wonder if they will have trouble enD.Lu-3/25/2010
10257Biogen Idec and Elan Enroll First Patient in Large, Well-Controlled Head-to-Headsim1-3/25/2010
10256Neuroimaging Technique Supports Reduction in Amyloid-Beta in Brains of Patients sim113/1/2010
10255I don't know much about Kelly Martin's personal habits. And, I don'Harold Engstrom12/23/2010
10254Ah! the sage words of Dr. Whitaker, attempting to bring reason to the game.....oArthur Radley-2/23/2010
10253The best example of that phenomenon was also one of the earliest - Tony O'Retom pope12/23/2010
10252Nothing against the good Irish people, but they seem to promote executives to ruArthur Radley-2/23/2010
10251Arthur, Elan is a study in how not to run a pharmaceutical company. It is one oHarold Engstrom-2/23/2010
10250Elan is my shoulda-coulda-wisha hadn't bought stock. I've just put it asArthur Radley-2/23/2010
10249Elan now needs to begin emphasizing results. The company continues to see TysabHarold Engstrom12/23/2010
10248FDA just announced new labeling requirements for Tysabri.........however, they eArthur Radley-2/5/2010
10247finance.yahoo.comArthur Radley-1/26/2010
10246Well, Glad to hear about this for MS patients but what an interesting few years steve kammerer-1/22/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News